LY294002 and sorafenib as inhibitors of intracellular survival pathways in the elimination of human glioma cells by programmed cell death

por A, Zając, J, Sumorek-Wiadro, A, Maciejczyk, E, Langner, I, Wertel, W, Rzeski, J, Jakubowicz-Gil
Publicado 2021